TFX
Teleflex Incorporated
Medical - Instruments & Supplies
Market Cap$5.45B
5Y Perf.-38.8%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
TFX vs ICU
Revenue, margins, valuation, and 5-year total return — side by side.
ICU
SeaStar Medical Holding Corporation
Biotechnology
Market Cap$29M
5Y Perf.-98.1%
TFX vs ICU — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | TFX | ICU |
|---|---|---|
| Industry | Medical - Instruments & Supplies | Biotechnology |
| Market Cap | $5.45B | $29M |
| Revenue (TTM) | $2.96B | $881K |
| Net Income (TTM) | $-906M | $-14M |
| Gross Margin | 53.3% | 95.3% |
| Operating Margin | 9.7% | -15.8% |
| Forward P/E | 18.3x | — |
| Total Debt | $2.73B | $574K |
| Cash & Equiv. | $393M | $2M |
TFX vs ICU — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
TFX
ICU
| Stock | Sep 22 | May 26 | Return |
|---|---|---|---|
| Teleflex Incorporat… (TFX) | 100 | 61.2 | -38.8% |
| SeaStar Medical Hol… (ICU) | 100 | 1.9 | -98.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: TFX vs ICU
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: TFX and ICU are tied at the top with 3 categories each — the right choice depends on your priorities. SeaStar Medical Holding Corporation is the stronger pick specifically for growth and revenue expansion and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
TFX
Teleflex Incorporated
The Long-Run Compounder
TFX carries the broadest edge in this set and is the clearest fit for long-term compounding.
- -15.1% 10Y total return vs ICU's -98.1%
- -30.6% margin vs ICU's -15.5%
- 1.1% yield; the other pay no meaningful dividend
Best for: long-term compounding
ICU
SeaStar Medical Holding Corporation
The Income Pick
ICU is the clearest fit if your priority is income & stability and growth exposure.
- beta 1.06
- Rev growth 12.0%, EPS growth 78.1%
- Lower volatility, beta 1.06, current ratio 0.55x
Best for: income & stability and growth exposure
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | ICU | 12.0% revenue growth vs TFX's -34.6% |
| Quality / Margins | TFX | -30.6% margin vs ICU's -15.5% |
| Stability / Safety | ICU | Beta 1.06 vs TFX's 1.06 |
| Dividends | TFX | 1.1% yield; the other pay no meaningful dividend |
| Momentum (1Y) | ICU | +280.5% vs TFX's +3.3% |
| Efficiency (ROA) | TFX | -12.3% ROA vs ICU's -88.0% |
TFX vs ICU — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
Segment breakdown not available.
TFX vs ICU — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLTFXLAGGINGICU
ICUSeaStar Medical Holdi…
1leads
TFXTeleflex Incorporated
2leads
6 Total Categories
CATEGORYLEADERvs ICUMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
Tied
—
Valuation MetricsMultiples, price ratios, and targets
TFX2/2
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
Tied
—
Total Returns1Y, 3Y, 5Y total returns with dividends
TFX4/6
Risk & VolatilityBeta, volatility, and downside exposure
ICU2/2
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
Evenly matched — TFX and ICU each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
TFX is the larger business by revenue, generating $3.0B annually — 3363.9x ICU's $881,000. Profitability is closely matched — net margins range from -30.6% (TFX) to -15.5% (ICU). On growth, ICU holds the edge at +169.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | TFXTeleflex Incorpor… | ICUSeaStar Medical H… |
|---|---|---|
| RevenueTrailing 12 months | $3.0B | $881,000 |
| EBITDAEarnings before interest/tax | $478M | -$14M |
| Net IncomeAfter-tax profit | -$906M | -$14M |
| Free Cash FlowCash after capex | $245M | -$14M |
| Gross MarginGross profit ÷ Revenue | +53.3% | +95.3% |
| Operating MarginEBIT ÷ Revenue | +9.7% | -15.8% |
| Net MarginNet income ÷ Revenue | -30.6% | -15.5% |
| FCF MarginFCF ÷ Revenue | +8.3% | -16.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | -28.5% | +169.1% |
| EPS Growth (YoY)Latest quarter vs prior year | -4.5% | +88.2% |
Evenly matched — TFX and ICU each lead in 3 of 6 comparable metrics.
Valuation Metrics
TFX leads this category, winning 2 of 2 comparable metrics.
Valuation Metrics
| Metric | TFXTeleflex Incorpor… | ICUSeaStar Medical H… |
|---|---|---|
| Market CapShares × price | $5.5B | $29M |
| Enterprise ValueMkt cap + debt − cash | $7.8B | $28M |
| Trailing P/EPrice ÷ TTM EPS | -6.09x | -0.73x |
| Forward P/EPrice ÷ next-FY EPS est. | 18.34x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 17.96x | — |
| Price / SalesMarket cap ÷ Revenue | 2.74x | 215.62x |
| Price / BookPrice ÷ Book value/share | 1.76x | — |
| Price / FCFMarket cap ÷ FCF | 22.22x | — |
TFX leads this category, winning 2 of 2 comparable metrics.
Profitability & Efficiency
Evenly matched — TFX and ICU each lead in 3 of 6 comparable metrics.
Profitability & Efficiency
TFX delivers a -23.7% return on equity — every $100 of shareholder capital generates $-24 in annual profit, vs $-119 for ICU. On the Piotroski fundamental quality scale (0–9), ICU scores 6/9 vs TFX's 5/9, reflecting solid financial health.
| Metric | TFXTeleflex Incorpor… | ICUSeaStar Medical H… |
|---|---|---|
| ROE (TTM)Return on equity | -23.7% | -119.2% |
| ROA (TTM)Return on assets | -12.3% | -88.0% |
| ROICReturn on invested capital | +3.4% | — |
| ROCEReturn on capital employed | +4.0% | — |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 |
| Debt / EquityFinancial leverage | 0.87x | — |
| Net DebtTotal debt minus cash | $2.3B | -$1M |
| Cash & Equiv.Liquid assets | $393M | $2M |
| Total DebtShort + long-term debt | $2.7B | $574,000 |
| Interest CoverageEBIT ÷ Interest expense | -0.95x | -209.88x |
Evenly matched — TFX and ICU each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
TFX leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in TFX five years ago would be worth $3,191 today (with dividends reinvested), compared to $190 for ICU. Over the past 12 months, ICU leads with a +280.5% total return vs TFX's +3.3%. The 3-year compound annual growth rate (CAGR) favors TFX at -21.1% vs ICU's -53.7% — a key indicator of consistent wealth creation.
| Metric | TFXTeleflex Incorpor… | ICUSeaStar Medical H… |
|---|---|---|
| YTD ReturnYear-to-date | +1.0% | +85.1% |
| 1-Year ReturnPast 12 months | +3.3% | +280.5% |
| 3-Year ReturnCumulative with dividends | -50.9% | -90.1% |
| 5-Year ReturnCumulative with dividends | -68.1% | -98.1% |
| 10-Year ReturnCumulative with dividends | -15.1% | -98.1% |
| CAGR (3Y)Annualised 3-year return | -21.1% | -53.7% |
TFX leads this category, winning 4 of 6 comparable metrics.
Risk & Volatility
ICU leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
ICU is the less volatile stock with a 1.06 beta — it tends to amplify market swings less than TFX's 1.06 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ICU currently trades 96.3% from its 52-week high vs TFX's 88.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | TFXTeleflex Incorpor… | ICUSeaStar Medical H… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.06x | 1.06x |
| 52-Week HighHighest price in past year | $139.63 | $5.05 |
| 52-Week LowLowest price in past year | $100.18 | $0.22 |
| % of 52W HighCurrent price vs 52-week peak | +88.3% | +96.3% |
| RSI (14)Momentum oscillator 0–100 | 44.9 | 59.8 |
| Avg Volume (50D)Average daily shares traded | 875K | 149K |
ICU leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
TFX is the only dividend payer here at 1.09% yield — a key consideration for income-focused portfolios.
| Metric | TFXTeleflex Incorpor… | ICUSeaStar Medical H… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | — |
| Price TargetConsensus 12-month target | $132.20 | — |
| # AnalystsCovering analysts | 29 | — |
| Dividend YieldAnnual dividend ÷ price | +1.1% | — |
| Dividend StreakConsecutive years of raises | 0 | — |
| Dividend / ShareAnnual DPS | $1.35 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +5.5% | 0.0% |
Insufficient data to determine a leader in this category.
Key Takeaway
TFX leads in 2 of 6 categories (Valuation Metrics, Total Returns). ICU leads in 1 (Risk & Volatility). 2 tied.
Best OverallTeleflex Incorporated (TFX)Leads 2 of 6 categories
Loading custom metrics...
TFX vs ICU: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is TFX or ICU a better buy right now?
Analysts rate Teleflex Incorporated (TFX) a "Buy" — based on 29 analyst ratings — the highest consensus in this comparison.
The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — TFX or ICU?
Over the past 5 years, Teleflex Incorporated (TFX) delivered a total return of -68.
1%, compared to -98. 1% for SeaStar Medical Holding Corporation (ICU). Over 10 years, the gap is even starker: TFX returned -15. 1% versus ICU's -98. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — TFX or ICU?
By beta (market sensitivity over 5 years), SeaStar Medical Holding Corporation (ICU) is the lower-risk stock at 1.
06β versus Teleflex Incorporated's 1. 06β — meaning TFX is approximately 0% more volatile than ICU relative to the S&P 500.
04Which is growing faster — TFX or ICU?
On earnings-per-share growth, the picture is similar: SeaStar Medical Holding Corporation grew EPS 78.
1% year-over-year, compared to -1468. 2% for Teleflex Incorporated. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — TFX or ICU?
Teleflex Incorporated (TFX) is the more profitable company, earning -45.
4% net margin versus -183. 9% for SeaStar Medical Holding Corporation — meaning it keeps -45. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TFX leads at 12. 8% versus -132. 2% for ICU. At the gross margin level — before operating expenses — ICU leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — TFX or ICU?
In this comparison, TFX (1.
1% yield) pays a dividend. ICU does not pay a meaningful dividend and should not be held primarily for income.
07Is TFX or ICU better for a retirement portfolio?
For long-horizon retirement investors, Teleflex Incorporated (TFX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
06), 1. 1% yield). Both have compounded well over 10 years (TFX: -15. 1%, ICU: -98. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between TFX and ICU?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
TFX pays a dividend while ICU does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(TFX: -28.5% · ICU: 169.1%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.